OOIR: Observatory of International Research

Papers

(The TQCC of Clinical Microbiology Reviews is 38. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
Extracutaneous sporotrichosis	305
Wild-type distributions of minimum inhibitory concentrations and epidemiological cut-off values—laboratory and clinical utility	265
Vaccines and monoclonal antibodies to prevent healthcare-associated bacterial infections	164
A Comprehensive Review on the Role of the Gut Microbiome in Human Neurological Disorders	160
Transmission of Infections during Cardiopulmonary Resuscitation	151
Antibiotic tolerance among clinical isolates: mechanisms, detection, prevalence, and significance	126
Erratum for Nyaruaba et al., “Digital PCR Applications in the SARS-CoV-2/COVID-19 Era: a Roadmap for Future Outbreaks”	125
Viral infections and pathogenesis of glaucoma: a comprehensive review	122
Membrane Technology for Rapid Point-of-Care Diagnostics for Parasitic Neglected Tropical Diseases	119
Sensitivity to Vaccines, Therapeutic Antibodies, and Viral Entry Inhibitors and Advances To Counter the SARS-CoV-2 Omicron Variant	102
HIV-associated cancers and lymphoproliferative disorders caused by Kaposi sarcoma herpesvirus and Epstein-Barr virus	101
Intestinal biofilms: pathophysiological relevance, host defense, and therapeutic opportunities	94
Progression of antibiotic resistance in Neisseria meningitidis	87
Clostridioides difficile infection: history, epidemiology, risk factors, prevention, clinical manifestations, treatment, and future options	83
Review of BCG immunotherapy for bladder cancer	82
Henipaviruses: epidemiology, ecology, disease, and the development of vaccines and therapeutics	81
Viral Respiratory Pathogens and Lung Injury	80
Evolutionary Pathways and Trajectories in Antibiotic Resistance	76
Non- faecium non- faecalis enterococci: a review of clinical manifestations, virulence factors, and antimicrobial resistance	71
Clonorchiasis and opisthorchiasis: epidemiology, transmission, clinical features, morbidity, diagnosis, treatment, and control	70
Neisseria gonorrhoeae vaccines: a contemporary overview	69
Congenital Syphilis: a Review of Global Epidemiology	64
Bacillus cereus Invasive Infections in Preterm Neonates: an Up-to-Date Review of the Literature	59
BCG therapy in bladder cancer and its tumor microenvironment interactions	54
Novel antifungals and treatment approaches to tackle resistance and improve outcomes of invasive fungal disease	53

Diagnosis, Management, and Future Control of Cholera	53
Aspergillus terreus Species Complex	51
Rapid and accurate testing for urinary tract infection: new clothes for the emperor	50
COVID-19 Convalescent Plasma and Clinical Trials: Understanding Conflicting Outcomes	50
The mRNA Vaccine Technology Era and the Future Control of Parasitic Infections	48
Trained Immunity as a Preventive Measure for Surgical Site Infections	47
Harnessing the host response for precision infectious disease diagnosis	46
Agnostic Sequencing for Detection of Viral Pathogens	45
Immunosuppressant imprecision: multidirectional effects on metabolism and microbiome	45
Lyme borreliosis in Brazil: a critical review on the Baggio–Yoshinari syndrome (Brazilian Lyme-like disease)	45
Artemisinin-resistant malaria	44
Mobile Oxazolidinone Resistance Genes in Gram-Positive and Gram-Negative Bacteria	44
Advances in the Microbiology of Stenotrophomonas maltophilia	43
Editorial Board	40
2021 Acknowledgment of CMR Reviewers	40
Clinical Laboratory Biosafety Gaps: Lessons Learned from Past Outbreaks Reveal a Path to a Safer Future	39
Editorial Board	39
The challenges of difficult-to-treat Acinetobacter infections	38